Pfizer Initiates Search for Successor to Dr. Mikael Dolsten as Chief Scientific Officer
Position
Chief Executive Officer
Company
Pfizer
Description
Pfizer Inc. has announced the initiation of the process to identify a successor for Dr. Mikael Dolsten, who currently serves as the Chief Scientific Officer and President of Pfizer Research & Development
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals promotes Samantha Pearce to Chief Commercial Officer (July 9, 2024)
- CASI Pharmaceuticals Appoints Daniel Lang, MD as Chief Financial Officer and Senior Vice President (July 8, 2024)
- AbbVie Appoints Roopal Thakkar, M.D. as Executive Vice President, R&D and Chief Scientific Officer (July 10, 2024)
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer (July 2, 2024)
- Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer (July 16, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
Who to call at Pfizer, and when
A new leader at Pfizer brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pfizer changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.